CAS 54965-22-9
:Fluspiperone
Description:
Fluspiperone is an antipsychotic medication primarily used in the treatment of schizophrenia and other psychiatric disorders. It belongs to the class of butyrophenones, which are characterized by their ability to antagonize dopamine receptors, particularly the D2 subtype. This action helps to alleviate symptoms of psychosis. Fluspiperone is known for its long half-life, allowing for less frequent dosing compared to some other antipsychotics. The compound is typically administered in its hydrochloride salt form, which enhances its solubility and bioavailability. In addition to its antipsychotic properties, fluspiperone has been studied for its potential use in treating conditions such as agitation and anxiety. Common side effects may include sedation, extrapyramidal symptoms, and metabolic changes, which are typical of many antipsychotic medications. Due to its pharmacological profile, fluspiperone is often used in clinical settings where long-term management of psychotic symptoms is required. As with any medication, careful monitoring and consideration of individual patient factors are essential for effective treatment.
Formula:C23H25F2N3O2
InChI:InChI=1/C23H25F2N3O2/c24-18-5-3-17(4-6-18)21(29)2-1-13-27-14-11-23(12-15-27)22(30)26-16-28(23)20-9-7-19(25)8-10-20/h3-10H,1-2,11-16H2,(H,26,30)
InChI key:InChIKey=RIOZXKPJYKSKJV-UHFFFAOYSA-N
SMILES:O=C1C2(N(CN1)C3=CC=C(F)C=C3)CCN(CCCC(=O)C4=CC=C(F)C=C4)CC2
Synonyms:- 1,3,8-Triazaspiro[4.5]Decan-4-One, 1-(4-Fluorophenyl)-8-[4-(4-Fluorophenyl)-4-Oxobutyl]-
- 1-(4-Fluorophenyl)-8-[4-(4-fluorophenyl)-4-oxobutyl]-1,3,8-triazaspiro[4.5]decan-4-one
- NSC 354855
- R 28930
- p-Fluorospiperone
- Fluspiperone
- NSC354855
- 8-[3-(4-Fluorobenzoyl)propyl]-1-(4-fluorophenyl)-1,3,8-triazaspiro[4.5]decan-4-one
- Fluspiperone USP/EP/BP
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
Fluspiperone
CAS:Fluspiperone is an antipsychotic agent.Formula:C23H25F2N3O2Purity:98%Color and Shape:SolidMolecular weight:413.46
